$LMB

Limbach Holdings earnings beat by $0.16, revenue topped estimates

Limbach Holdings (LMB) reported Q3 EPS of $1.37, beating estimates by $0.16, with revenue of $230.5M, exceeding expectations. The company guided FY 2026 revenue to $760M-$790M, below consensus. LMB's stock is up 2.51% over 3 months but down 45.02% over 12 months, with 5 negative EPS revisions in 90 days.

Original reporting
Published Nov 3, 2026, 9:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 9:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$LMB
Bearish
high confidence
Mentioned
$LMB
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$LMBBearishHigh
01

Why it matters

The mixed results create short-term volatility; investors may weigh the beat against the guidance miss.

02

Market read

Earnings release provides fresh data for traders; the guidance shortfall may drive near-term price pressure.

03

What to watch

Potential upside from upcoming product launches or contract wins not disclosed in this release.

Relevance 7/10Novelty 8/10Timing: after-hours reaction

Background

Limbach Holdings (NASDAQ:LMB) is a small-cap firm whose recent earnings beat estimates but issued revenue guidance below consensus.

Company-level read

Ticker impact

$LMBBearishHigh confidence
Context

Limbach Holdings reported Q3 EPS of $1.37 beating estimates by $0.16 and revenue of $230.5M topping consensus, with FY2026 revenue guidance below analyst expectations.

Expected impact

likely pressure as the market prices in the revenue guidance shortfall

Evidence & confidence

Investors often penalize stocks when guidance falls short despite an earnings beat, especially for small-cap names.

Market effects

Limited; the earnings surprise may affect peers in the same niche but no broad sector shift.

Minimal; the company is US-listed with modest market cap.

Low; no global macro implications.

Counterpoint

Despite guidance miss, the earnings beat could attract short-covering rallies if the stock is oversold.

Key entities

  • Limbach Holdings

    US-listed small-cap reporting Q3 earnings.

Related articles

$LMBMed

Limbach Reports Third Quarter 2026 Results

Limbach Holdings, Inc. (LMB) filed an SEC Form 8-K — Results of Operations and Financial Condition. FOR IMMEDIATE RELEASE Limbach Reports Third Quarter 2026 Results Expects Full-Year 2026 Revenue and Adjusted EBITDA to be At or Near the High End of Guidance TAMPA, Fla. – November 3, 2026 – Limbach Holdings, Inc. (Nasdaq: LMB) (“Limbach” or the “Company”), a building systems sol

$LMBMed

JPMorgan downgrades Limbach stock rating on valuation concerns

JPMorgan downgraded Limbach Holdings (LMB) to Underweight, lowering its price target to $50 from $60. The stock is near its 52-week low at $42.75. Five analysts revised earnings downward. The company reported Q2 2026 earnings and revenue below expectations, with near-term margin pressures cited. Stifel lowered its price target to $86 but maintained a Buy rating.

$LMBMedAI 8/10

Why Limbach Is Buying CYMCOR For $30 Million

Limbach Holdings said it acquired CYMCOR for about $30 million to expand in data center infrastructure services. The deal, funded via cash and borrowings under its revolving credit facility, is expected to add about $12 million of professional services revenue and $4 million of adjusted EBITDA in 2027. CYMCOR manages projects with over $8 billion in budgets.

$LMBMedAI 8/10

Read Analyst Questions From Limbach’s Q2 Earnings Call

Limbach (LMB) reported Q2 revenue of $173.5M, below analysts’ $177.3M estimate, and adjusted EPS of $0.64 versus $0.93 expected. Adjusted EBITDA was $13.94M versus $19.6M expected, with operating margin at 4.3%. CEO Michael McCann cited project timing and softer healthcare and institutional demand. Full-year revenue guidance was raised to $775M midpoint, but EBITDA guidance was below estimates.